Life Sciences

National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under the Department of Biotechnology, Government of India. NABI aims at catalysing the transformation of the Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security.

Biotechnology Industry Research Assistance Council (BIRAC) a Public Sector Undertaking of the Department of Biotechnology, Ministry of Science & Technology, and Government of India has been entrusted the responsibility of implementing this Program. It will house the Program Management Unit (PMU) that would work as an operational and functional arm to oversee and monitor program implementation.

Post : Regulatory / Policy Interns under Regulatory Affairs & Policy Advocacy (RAPA)

CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) is a premier multidisciplinary research institute of Council of  Scientific and Industrial Research (CSIR), India with its major focus on exploiting the potential of medicinal and aromatic  plants (MAPs) by cultivation, bioprospection, chemical characterization, extraction, and formulation of bioactive phytomolecules.

Aurigene is a clinical stage biotech company engaged in discovery and clinical development of novel and best-in-class therapies to treat cancer, and a wholly owned subsidiary of Dr Reddy's Laboratories Ltd. Aurigene is focused on precision - oncology and has multiple compounds at different stages of pre-clinical development and several projects in global clinical development.

Post : Cell & Gene Therapy - Manufacturing - Scientist & Research Associate

Reliance Life Sciences is a medical biotechnology-led company engaged in research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals. Three core businesses of RLS are plasma proteins, biosimilars, and later generation oncology pharmaceuticals. In addition, it has initiatives in clinical research, molecular medicine, regenerative medicine, genetherapy, peptides and oligonucleotides.